Transcatheter Arterial Infusion Chemoembolization Combined with 3 Dimensional Conformal Radiotherapy for Primary Hepatic Carcinoma
MU Li-xiang
Abstract
MU Li-xiang
Abstract
Objective To evaluate curative efficiency of transcatheter arterial chemoembolization(TACE) combined with 3 dimensional conformal radiotherapy(3DCRT) for advanced primary hepatic carcinoma(PHC). Methods 60 patients with advanced stage PHC were randomly divided into 2 groups(treatment group and control group): 30 patients of treatment group was treated with TACE combined with 3DCRT,30 patients of control group was treated with TACE only.TACE was performed with sandwich therapy,3DCRT was performed after TACE in 2 weeks and received 2.0 Gy per fraction,five fractions a week with the total doses of 60 Gy. Results For treatment group and control group,the efficiency rates(CR+PR) were 63.4% and 36.7%(P0.05) respectively;The one year local control rates were respectively 66.7%,43.3%(P0.01) and one year survival rates were 86.7%,73.3%(P0.05) respectively. Conclusion It shows significant efficiency for TACE combined with 3DCRT for advanced PHC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate curative efficiency of transcatheter arterial chemoembolization(TACE) combined with 3 dimensional conformal radiotherapy(3DCRT) for advanced primary hepatic carcinoma(PHC). Methods 60 patients with advanced stage PHC were randomly divided into 2 groups(treatment group and control group): 30 patients of treatment group was treated with TACE combined with 3DCRT,30 patients of control group was treated with TACE only.TACE was performed with sandwich therapy,3DCRT was performed after TACE in 2 weeks and received 2.0 Gy per fraction,five fractions a week with the total doses of 60 Gy. Results For treatment group and control group,the efficiency rates(CR+PR) were 63.4% and 36.7%(P0.05) respectively;The one year local control rates were respectively 66.7%,43.3%(P0.01) and one year survival rates were 86.7%,73.3%(P0.05) respectively. Conclusion It shows significant efficiency for TACE combined with 3DCRT for advanced PHC.
Key concepts: Medicine, Transcatheter arterial chemoembolization, Hepatocellular carcinoma, Radiation therapy, Carcinoma, Urology, Internal medicine, Radiology